BioNTech 20. Apr. 2026 Assessing BioNTech (NasdaqGS:BNTX) Valuation After Recent Share Price Momentum - simplywall.st
BioNTech 18. Apr. 2026 BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
FierceBiotech 13. Apr. 2026 BioNTech, SynOx plot paths to FDA as trials hit goals in competitive tumor types
BioNTech 2. Apr. 2026 BioNTech telegraphs closure of Singapore vaccine facility amid efforts to 'align capacity' - Fierce Pharma
BioNTech 2. Apr. 2026 Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles - Reuters
Endpoints News 14. März 2026 Roche’s breast cancer failure; BioNTech co-founders to depart; Eli Lilly’s quest to stay on top; and more
Endpoints News 2. März 2026 Aardvark's stock plummets on study pause; BioNTech heads to Phase 3 with DualityBio ADC
FierceBiotech 28. Feb. 2026 BioNTech advances DualityBio ADC into phase 3 with half the patients of Merck-Daiichi rival
Endpoints News 9. Dez. 2025 #SABCS25: BioNTech, BMS unwrap Phase 2 data for PD-L1xVEGF-A bispecific in breast cancer